Hagen Sander M, van Alphen Arjan M, Ijzermans Jan N M, Dor Frank J M F
Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
BMC Surg. 2011 Dec 20;11:35. doi: 10.1186/1471-2482-11-35.
Peritoneal dialysis (PD) is an effective treatment for end-stage renal disease. It allows patients more freedom to perform daily activities compared to haemodialysis. Key to successful PD is the presence of a well-functioning dialysis catheter. Several complications, such as in- and outflow obstruction, peritonitis, exit-site infections, leakage and migration, can lead to catheter removal and loss of peritoneal access. Currently, different surgical techniques are in practice for PD-catheter placement. The type of insertion technique used may greatly influence the occurrence of complications. In the literature, up to 35% catheter failure has been described when using the open technique and only 13% for the laparoscopic technique. However, a well-designed randomized controlled trial is lacking.
METHODS/DESIGN: The LOCI-trial is a multi-center randomized controlled, single-blind trial (pilot). The study compares the laparoscopic with the open technique for PD catheter insertion. The primary objective is to determine the optimum placement technique in order to minimize the incidence of catheter malfunction at 6 weeks postoperatively. Secondary objectives are to determine the best approach to optimize catheter function and to study the quality of life at 6 months postoperatively comparing the two operative techniques.
This study will generate evidence on any benefits of laparoscopic versus open PD catheter insertion.
Dutch Trial Register NTR2878.
腹膜透析(PD)是终末期肾病的一种有效治疗方法。与血液透析相比,它使患者在进行日常活动时有更多的自由。成功进行腹膜透析的关键是要有一根功能良好的透析导管。一些并发症,如流入和流出梗阻、腹膜炎、出口处感染、渗漏和移位,可导致导管拔除和腹膜通路丧失。目前,腹膜透析导管置入有不同的手术技术在应用。所采用的插入技术类型可能会极大地影响并发症的发生。在文献中,使用开放技术时导管失败率高达35%,而腹腔镜技术仅为13%。然而,缺乏精心设计的随机对照试验。
方法/设计:LOCI试验是一项多中心随机对照单盲试验(试点)。该研究比较腹腔镜技术与开放技术进行腹膜透析导管置入。主要目的是确定最佳的置入技术,以尽量减少术后6周时导管故障的发生率。次要目的是确定优化导管功能的最佳方法,并比较两种手术技术,研究术后6个月时的生活质量。
本研究将提供关于腹腔镜与开放腹膜透析导管置入术任何益处的证据。
荷兰试验注册编号NTR2878。